Skip to main content
Medical information Clinical review pending

Fungal Testing

Malassezia Species Quantitative Test

A test to detect and measure the amount of Malassezia fungi in skin lesions, particularly useful for conditions like Atopic Dermatitis.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Skin scraping or biopsy sample from the affected lesion.
Results
Confirm with the laboratory before booking.
Preparation
Confirm specific preparation instructions with the laboratory before booking. Generally, the affected skin area should be clean and free from topical creams or ointments prior to sample collection.
Test priceKSh 13,600

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Malassezia Species Quantitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Persistent erosive skin lesions
  • ✓Erythematous skin lesions
  • ✓Lichenoid skin lesions
  • ✓Suspected fungal involvement in Atopic Dermatitis
  • ✓Monitoring response to antifungal therapy
  • ✓Diagnosis of Malassezia-related skin conditions
02

In plain language

What this test helps you understand

This test helps identify and quantify Malassezia fungi in skin lesions, aiding in the diagnosis and management of conditions potentially associated with fungal overgrowth, such as certain types of Atopic Dermatitis.
The Malassezia Species Quantitative Test is a specialized diagnostic tool used to identify and quantify Malassezia fungi within skin lesions. This test is especially relevant for individuals presenting with erosive, erythematous, or lichenoid skin conditions, often associated with Atopic Dermatitis (AD). Determining the fungal load can assist healthcare providers in developing targeted and effective treatment strategies.

This test measures the quantity of Malassezia species found in skin samples. It utilizes the Real-Time PCR method for accurate and reliable results, helping clinicians assess the extent of fungal involvement in various skin conditions.

Patients who might benefit from this test include those with persistent skin lesions (erosive, erythematous, or lichenoid), individuals with a history of Atopic Dermatitis or similar conditions potentially worsened by fungal infections, and those experiencing symptoms like itching, redness, or discomfort in affected skin areas.

Taking this test can provide accurate identification of fungal infections, aiding in effective treatment. It also helps monitor the effectiveness of antifungal therapies and guides dermatologists in making informed patient care decisions.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm specific preparation instructions with the laboratory before booking. Generally, the affected skin area should be clean and free from topical creams or ointments prior to sample collection.
SampleSkin scraping or biopsy sample from the affected lesion.
MethodologyReal-Time PCR (Polymerase Chain Reaction)
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects Malassezia species but does not identify the specific species. Results should be interpreted in conjunction with clinical findings and other diagnostic tests. The presence of Malassezia does not always indicate infection or the need for treatment.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Malassezia is a type of yeast (fungus) that commonly lives on human skin. In some individuals, it can contribute to skin conditions like Atopic Dermatitis.
The test measures the *amount* (quantity) of Malassezia fungi present in the skin sample, not just whether it's present or not. This helps assess the severity of fungal involvement.
Sample collection is typically performed by a qualified healthcare professional, such as a dermatologist or nurse, during a clinical examination.
Your doctor will interpret the results in the context of your clinical presentation and medical history. A higher quantity may indicate a greater fungal load.
Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp